Showing results (141-150 of 237) with videos related to
Sort By:
Pageof 24
Diabetes, Obesity & Metabolism|January 9, 2025
Cardiovascular, kidney and safety outcomes with canagliflozin in older adults: A combined analysis from the CANVAS Program and CREDENCE trialAmanda Siriwardana, Luke Buizen, Min Jun, et al.Annals of Work Exposures and Health|September 29, 2021
Diesel Engine Exhaust Exposure in the Ontario Civil Infrastructure Construction IndustryStephanie Ziembicki, Tracy L Kirkham, Paul A Demers, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 15, 2012
Prediction of kidney-related outcomes in patients with type 2 diabetesMeg J Jardine, Jun Hata, Mark Woodward, et al.BMJ Open|February 21, 2019
Randomised controlled trial of the impact of haemodiafiltration on uraemic neuropathy: FINESSE study protocolBrendan Smyth, Arun V Krishnan, Martin Gallagher, et al.Stroke|April 20, 2021
Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-AnalysisZien Zhou, Meg J Jardine, Qiang Li, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 24, 2020
Relative and Absolute Risk Reductions in Cardiovascular and Kidney Outcomes With Canagliflozin Across KDIGO Risk Categories: Findings From the CANVAS ProgramBrendon L Neuen, Toshiaki Ohkuma, Bruce Neal, et al.Plant, Cell & Environment|December 13, 2016
Monoterpene 'thermometer' of tropical forest-atmosphere response to climate warmingKolby J Jardine, Angela B Jardine, Jennifer A Holm, et al.Journal of the American Heart Association|January 30, 2020
Sodium-Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-AnalysisClare Arnott, Qiang Li, Amy Kang, et al.Kidney International Reports|May 20, 2024
Calciphylaxis Episodes in the Australia and New Zealand Dialysis and Transplant RegistryNigel D Toussaint, Christopher E Davies, Elisa Bongetti, et al.Diabetes, Obesity & Metabolism|May 22, 2020
The effect of canagliflozin on amputation risk in the CANVAS program and the CREDENCE trialClare Arnott, Yuli Huang, Brendon L Neuen, et al.Pageof 24